US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist
  • 54.690
  • -0.230-0.42%
Trading Oct 15 11:16 ET
137.12BMarket Cap29.84P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Q3 2024 Estimates Date

Currency：EUROct 25, 2024

Estimate YoY
Revenue
12.67B
+5.87%
EPS
1.02
+1.64%
Analyst Rating
Strong Buy

Oct 11, 2024

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jan 30, 20252024/Q4-- / 11.892B--
Oct 25, 20242024/Q3-- / 12.667B--
Jul 25, 20242024/Q210.745B / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--
DatePeriodRevenue/EstimateEarnings Call
Jan 30, 20252024/Q4-- / 11.892B--
Oct 25, 20242024/Q3-- / 12.667B--
Jul 25, 20242024/Q210.745B / 10.377B--
Apr 25, 20242024/Q110.464B / 10.208B--
Feb 1, 20242023/Q410.919B / 10.989B--

Unlock Free Earnings Estimates

Sanofi Earnings Reports

  • 6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

    Jul 25 11:48 ET

  • 6-K: 2024 Half-Year Financial Report

    Jul 25 10:29 ET

  • Sanofi | 6-K: Colletion of Recent Announcements

    May 2 15:56 ET

  • Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

    Apr 25 10:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 11, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday0.00%